639,366 Shares in Endava plc (NYSE:DAVA) Purchased by Paradice Investment Management LLC

Paradice Investment Management LLC purchased a new stake in shares of Endava plc (NYSE:DAVAFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 639,366 shares of the company’s stock, valued at approximately $18,695,000. Endava accounts for 3.3% of Paradice Investment Management LLC’s holdings, making the stock its 17th biggest position. Paradice Investment Management LLC owned approximately 1.11% of Endava as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. US Bancorp DE grew its position in shares of Endava by 2,113.9% during the 4th quarter. US Bancorp DE now owns 16,427 shares of the company’s stock valued at $1,279,000 after acquiring an additional 15,685 shares during the period. George Kaiser Family Foundation bought a new stake in shares of Endava in the first quarter valued at $1,136,000. SG Americas Securities LLC purchased a new position in shares of Endava during the 1st quarter valued at $832,000. Neuberger Berman Group LLC bought a new position in shares of Endava during the 4th quarter worth $1,837,000. Finally, Russell Investments Group Ltd. increased its holdings in Endava by 74.7% in the 4th quarter. Russell Investments Group Ltd. now owns 115,390 shares of the company’s stock worth $8,983,000 after acquiring an additional 49,344 shares during the last quarter. Hedge funds and other institutional investors own 62.23% of the company’s stock.

Endava Trading Down 0.9 %

Shares of DAVA traded down $0.30 during trading hours on Monday, reaching $31.97. 133,500 shares of the company’s stock traded hands, compared to its average volume of 528,224. The firm’s 50 day simple moving average is $30.18 and its 200-day simple moving average is $33.65. The stock has a market cap of $1.85 billion, a PE ratio of 35.52 and a beta of 1.22. Endava plc has a 12 month low of $24.51 and a 12 month high of $81.06.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DAVA. Redburn Atlantic began coverage on shares of Endava in a research report on Friday, May 24th. They set a “neutral” rating and a $33.10 target price for the company. Needham & Company LLC lowered their target price on shares of Endava from $50.00 to $42.00 and set a “buy” rating on the stock in a report on Friday, May 24th. TD Cowen dropped their target price on Endava from $46.00 to $42.00 and set a “buy” rating on the stock in a research report on Friday, May 24th. Wedbush decreased their price objective on Endava from $65.00 to $50.00 and set an “outperform” rating on the stock in a research note on Thursday, May 23rd. Finally, Guggenheim cut their target price on Endava from $60.00 to $55.00 and set a “buy” rating for the company in a research note on Friday, May 24th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Endava presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.41.

Read Our Latest Analysis on DAVA

About Endava

(Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Featured Articles

Institutional Ownership by Quarter for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.